Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

American Journal of Medicine

Volumn 110, Issue 8, 2001, Pages 605-609

  Domingo, Pere ^a,b   Torres, Olga H ^a   Ris, Josep ^a   Vazquez, Guillermo ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEVER; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SEX DIFFERENCE; T LYMPHOCYTE;

ADULT; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FEMALE; HERPES ZOSTER; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS;

EID: 0035369893     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00703-3     Document Type: Article

References (35)

1. Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine
2. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus
3. Herpes zoster and human immunodeficiency virus infection: A cohort study of 101 coinfected patients
4. Herpes zoster and human immunodeficiency virus infection
5. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection
6. Herpes zoster in African patients: A clinical predictor of human immunodeficiency virus infection
7. Risk of AIDS after herpes zoster
8. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
9. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
10. 6 cells/L following combination antiretroviral therapy including protease inhibitors
11. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
12. Immune recovery inflammatory folliculitis
13. Antiretroviral therapy in adults. Updated recommendations of the International AIDS society-USA panel
14. Herpes zoster and postherpetic neuralgia
15. Postherpetic neuralgia: A review
16. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
17. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 in plasma: Application to acute retroviral infection
18. Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy
19. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors
20. Mycobacterial lymphadenitis associated with the initiation of combination antiretrovial therapy
21. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
22. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
23. A short-term study of the safety, pharamacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease
24. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine
25. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
26. Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Cohort Study and the Multicenter Hemophilia Cohort Study
27. Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus
28. Varicella and herpes zoster: Changing concepts of the natural history, control, and importance of a not-so-benign virus
29. Varicella-zoster virus: Aspects of pathogenesis and host response to natural infection and varicella vaccine
30. Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine
31. Recovery of the immune system with antiretroviral therapy
32. CD8 lymphocyte responses to antiviral therapy of HIV infection
33. Analysis of immune function in herpes zoster patients: Demonstration and characterization of suppressor cells